Archives
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Liproxstatin-1: Potent Ferroptosis Inhibitor for Lipid Pe...
2026-01-26
Liproxstatin-1 is a potent ferroptosis inhibitor (IC50 22 nM) enabling precise modulation of lipid peroxidation in GPX4-deficient and iron-dependent cell death models. This article details its mechanism, benchmarks, and best practices for integration in ferroptosis research.
-
DIDS: Advanced Mechanisms and Emerging Roles in Cancer an...
2026-01-26
Explore the multifaceted actions of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid), a premier anion transport inhibitor, with a deep dive into its unique molecular mechanisms and translational applications in cancer research and neurodegenerative disease models. This article offers a distinct, evidence-driven perspective on how DIDS is redefining chloride channel modulation and therapeutic innovation.
-
Sulfaphenazole: Strategic CYP2C9 Inhibition for Transform...
2026-01-25
This thought-leadership article examines Sulfaphenazole as a highly selective competitive CYP2C9 inhibitor, illuminating its mechanistic impact on drug metabolism, vascular endothelial function, and ischemia–reperfusion injury. Blending recent in vivo evidence and translational strategy, we delineate how APExBIO's Sulfaphenazole (C4131) empowers researchers to unravel pharmacogenetic complexities, modulate oxidative stress, and set new benchmarks for adverse drug reaction modeling beyond conventional product descriptions.
-
MDL 28170: Selective Calpain and Cathepsin B Inhibition f...
2026-01-24
MDL 28170 is a selective, cell-permeable calpain and cathepsin B inhibitor widely used in apoptosis and neuroprotection research. Its specificity, blood-brain barrier permeability, and nanomolar potency make it a benchmark tool for dissecting calpain-mediated proteolysis in ischemia-reperfusion and neurodegenerative models.
-
Q-VD-OPh: Pan-Caspase Inhibition as a Precision Tool for ...
2026-01-23
Explore the multifaceted roles of Q-VD-OPh, a potent pan-caspase inhibitor, in apoptosis research and mitochondrial quality control. This article uniquely connects irreversible caspase inhibition to emerging insights on mitophagy and disease modeling, providing advanced perspectives for experimental design.
-
U 46619 (SKU B6890): Practical Solutions for Reliable Pla...
2026-01-23
This article delivers scenario-based guidance for biomedical researchers and lab technicians seeking reproducible cell viability, platelet aggregation, and renal ischemia-reperfusion assays using U 46619 (SKU B6890). Drawing on quantitative data, peer-reviewed literature, and direct product comparisons, it demonstrates how U 46619 provides reliable, validated results and practical workflow advantages for demanding laboratory settings.
-
Pseudo-Modified Uridine Triphosphate (Pseudo-UTP): From M...
2026-01-22
This thought-leadership article illuminates the transformative role of pseudo-modified uridine triphosphate (Pseudo-UTP) in advancing mRNA vaccine and gene therapy pipelines. Integrating molecular mechanisms, peer-reviewed validation, and actionable strategy, it guides translational researchers through the evolving landscape of RNA modification, focusing on how Pseudo-UTP accelerates clinical innovation by enhancing RNA stability, translation efficiency, and reducing immunogenicity. With reference to recent breakthroughs and APExBIO’s high-purity offering, this piece provides a comprehensive resource that goes beyond standard product overviews.
-
S Tag Peptide: Fusion Tag for Enhanced Protein Solubility...
2026-01-22
Discover how the S Tag Peptide transforms protein engineering workflows as a versatile solubility enhancer and detection tag. Learn stepwise protocols, advanced applications in single-molecule imaging, and troubleshooting strategies that empower reproducible, high-sensitivity results across molecular biology platforms.
-
(S)-Mephenytoin (SKU C3414): Reliable CYP2C19 Assays for ...
2026-01-21
This comprehensive article addresses real-world challenges in drug metabolism and pharmacokinetic studies using (S)-Mephenytoin (SKU C3414) as a gold-standard CYP2C19 substrate. Drawing from current literature and validated protocols, it guides biomedical researchers, lab technicians, and postgraduates through experimental design, optimization, and vendor selection—emphasizing the reproducibility and reliability of (S)-Mephenytoin sourced from APExBIO.
-
MG-132 Proteasome Inhibitor: Applied Protocols & Troubles...
2026-01-21
MG-132, a potent cell-permeable proteasome inhibitor peptide aldehyde, is central to apoptosis research, cell cycle arrest studies, and oxidative stress investigations. This article delivers stepwise protocols, advanced applications, and expert troubleshooting tips to maximize the utility of MG-132 in molecular and cancer biology workflows.
-
Scenario-Driven Insights: FerroOrange (Fe²⁺ indicator) fo...
2026-01-20
This article provides an authoritative, scenario-based guide to using FerroOrange (Fe²⁺ indicator, SKU C8004) for reproducible and sensitive live cell ferrous ion detection. Grounded in recent literature and real laboratory challenges, it demonstrates how FerroOrange (Fe²⁺ indicator) empowers researchers with robust intracellular iron measurement for cell viability, proliferation, and cytotoxicity assays. Explore validated approaches and product selection strategies that optimize experimental outcomes.
-
Lipo3K Transfection Reagent: High Efficiency for Difficul...
2026-01-20
Lipo3K Transfection Reagent redefines high efficiency nucleic acid transfection, especially in challenging cell lines, by combining low cytotoxicity with exceptional performance. Its innovative nuclear enhancement and compatibility with complex workflows enable robust gene expression and RNA interference studies with reproducible results. Experience seamless DNA and siRNA co-transfection, even in the most demanding experimental setups.
-
Strategic Harnessing of Ionomycin Calcium Salt: Advancing...
2026-01-19
This thought-leadership article provides translational researchers with a mechanistic, evidence-driven, and strategically actionable roadmap for leveraging Ionomycin calcium salt in cancer research. Integrating foundational biology, experimental validation, competitive context, and clinical potential, we explore how precision modulation of intracellular Ca2+—enabled by APExBIO’s Ionomycin calcium salt—can redefine apoptosis induction, tumor growth inhibition, and therapeutic innovation beyond the scope of standard product literature.
-
Concanamycin A (SKU A8633): Enhancing Reproducibility in ...
2026-01-19
Discover how Concanamycin A (SKU A8633) from APExBIO addresses persistent challenges in V-ATPase inhibition workflows for cancer biology research. This evidence-driven guide explores practical scenarios, validated protocols, and comparative insights to help biomedical researchers achieve reliable, sensitive, and reproducible results.
-
Sulfo-NHS-SS-Biotin Kit: Reversible, Water-Soluble Biotin...
2026-01-18
The Sulfo-NHS-SS-Biotin Kit enables reversible, water-soluble biotinylation of protein and antibody surfaces, supporting selective and high-fidelity cell surface protein labeling. This amine-reactive reagent provides a robust, non-permeant approach for mapping extracellular interactomes, as demonstrated in advanced glycoRNA and RBP discovery studies.
15686 records 10/1046 page Previous Next First page 上5页 678910 下5页 Last page